First human tests begin for new epilepsy pill
NCT ID NCT06899230
Summary
This is a very early study to check if a new oral drug called iQ-007 is safe for people and how the body processes it. The study involves 72 healthy adult volunteers, not people with epilepsy. Researchers will give participants single or multiple doses and closely monitor them for any side effects. The goal is to gather basic safety information to see if the drug can move forward for testing in people with drug-resistant epilepsy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.